Division of Vascular and Endovascular Surgery, Department of Surgery, University of Hong Kong Medical Center, Pokfulam, Hong Kong.
Division of Vascular and Endovascular Surgery, Department of Surgery, University of Hong Kong Medical Center, Pokfulam, Hong Kong.
Asian J Surg. 2018 Sep;41(5):490-497. doi: 10.1016/j.asjsur.2017.09.004. Epub 2017 Dec 9.
The study aims to report outcomes of open repair (OR) and endovascular aneurysm repair (EVAR) in octogenarians.
Consecutive patients aged between 80 and 89 who underwent OR or EVAR were identified from a prospectively collected departmental database. Short-term outcomes included 30 days mortalities and perioperative complications; long-term outcomes included overall survival and re-intervention using the Kaplan-Meier method. Logistic regression was used to identify predictors for operative mortality and Cox regression analysis was used to identify predictors for long-term survival.
From January 1999 to December 2013, 53 underwent open repairs (23 emergency and 30 elective) and 115 underwent endovascular repairs (11 emergency and 104 elective). For elective procedures, 30 days operative mortalities were 6.7% and 0% in OR and EVAR respectively (Chi square test, p = 0.049). For emergency procedures, 30 days mortalities were 39.1% and 27.2% respectively (Chi square test, p = 0.705). Overall 5 years survival rates were 40.4% and 36.7% after OR and EVAR respectively. Rupture of aneurysm (Odd ratio 18.8, 95% CI 3.4-104.5, p = 0.001) was the only predictor for 30 days mortality. Rupture of aneurysm (Hazard ratio 2.0, 95% CI 1.3-3.3, p = 0.003), history of lung disease (Hazard ratio 1.7, 95% CI 1.0-2.9, p = 0.039) and history of renal disease (Hazard ratio 2.1, 95% CI 1.4-3.1, p < 0.001) were independent predictors for long-term overall survival.
Decision of AAA repair in octogenarians should not be based on age alone. Both elective OR and EVAR had acceptable perioperative risk, but emergency repair, lung disease and renal impairment predicted poor long-term survival.
本研究旨在报告 80 岁及以上患者行开放修复术(OR)和血管内修复术(EVAR)的结果。
从一个前瞻性收集的部门数据库中确定了年龄在 80 至 89 岁之间接受 OR 或 EVAR 的连续患者。短期结果包括 30 天死亡率和围手术期并发症;长期结果包括使用 Kaplan-Meier 方法的总体生存率和再干预。使用逻辑回归识别手术死亡率的预测因素,使用 Cox 回归分析识别长期生存率的预测因素。
从 1999 年 1 月至 2013 年 12 月,53 例行开放修复术(23 例急诊和 30 例择期),115 例行血管内修复术(11 例急诊和 104 例择期)。对于择期手术,OR 和 EVAR 的 30 天手术死亡率分别为 6.7%和 0%(卡方检验,p=0.049)。对于急诊手术,30 天死亡率分别为 39.1%和 27.2%(卡方检验,p=0.705)。OR 和 EVAR 术后 5 年总生存率分别为 40.4%和 36.7%。动脉瘤破裂(优势比 18.8,95%置信区间 3.4-104.5,p=0.001)是 30 天死亡率的唯一预测因素。动脉瘤破裂(风险比 2.0,95%置信区间 1.3-3.3,p=0.003)、肺部疾病史(风险比 1.7,95%置信区间 1.0-2.9,p=0.039)和肾脏疾病史(风险比 2.1,95%置信区间 1.4-3.1,p<0.001)是长期总体生存的独立预测因素。
80 岁以上患者 AAA 修复的决策不应仅基于年龄。择期 OR 和 EVAR 的围手术期风险均可接受,但急诊修复、肺部疾病和肾功能不全预测长期生存不良。